Equities

Artivion Inc

Artivion Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)25.45
  • Today's Change0.305 / 1.21%
  • Shares traded83.16k
  • 1 Year change+70.09%
  • Beta1.7433
Data delayed at least 15 minutes, as of Sep 20 2024 15:39 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Artivion Inc had net income fall 59.91% from a loss of 19.19m to a larger loss of 30.69m despite revenues that grew 12.82% from 313.79m to 354.00m over the same period.
Gross margin64.63%
Net profit margin-2.22%
Operating margin7.98%
Return on assets-1.07%
Return on equity-2.88%
Return on investment-1.15%
More ▼

Cash flow in USDView more

In 2023, Artivion Inc increased its cash reserves by 49.78%, or 19.59m. The company earned 18.83m from its operations for a Cash Flow Margin of 5.32%. In addition the company generated 865.00k cash from financing while 502.00k was spent on investing.
Cash flow per share0.3628
Price/Cash flow per share70.16
Book value per share7.06
Tangible book value per share-2.71
More ▼

Balance sheet in USDView more

Artivion Inc has a Debt to Total Capital ratio of 51.77%, a lower figure than the previous year's 109.57%.
Current ratio5.63
Quick ratio4.04
Total debt/total equity1.07
Total debt/total capital0.5177
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -57.29%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
70.35
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.